Options, Warrants, etc. a. The Company has outstanding options to purchase a total of 3,151,756 shares of its common stock under its 1998 Stock Option Plan as of the date of the Stock Purchase Agreement. The name of each optionholder and the number of shares represented by each option grant is set forth on attached Schedule 2 to Disclosure Schedule 3.8, dated as of the date of the Stock Purchase Agreement. Pursuant to an Information Memorandum of the Company dated September 29, 2003, the Company is offering to repurchase for cash an aggregate of approximately $91 million, but not less than $70 million, worth of its outstanding common stock, $0.01 par value per share and outstanding options and warrants to purchase such stock. b. On December 18, 1998, the Company issued to ReliaStar Financial Corp. ("Reliastar") a warrant (the "Warrant") to purchase 245,000 shares of the Company's common stock at an exercise price of $.01 per share. The Warrant was issued in connection with the Preferred Stock and Warrant Purchase Agreement, dated as of December 18, 1998, between the Company and Reliastar. The Warrant was subsequently transferred by Reliastar to Security Life of Denver Insurance Company, an affiliate of Reliastar. Pursuant to an Information Memorandum of the Company dated September 29, 2003, the Company is offering to repurchase outstanding options and warrants to purchase its common stock. Under the letter agreement dated September 26, 2003 between the Company and Security Life of Denver Insurance Company, Security Life of Denver Insurance Company agreed that the Company will repurchase the Warrant concurrently with the closing of the Credit Agreement. ## Denotes confidential information that has been omitted from the exhibit and filed separately, accompanied by a confidential treatment request, with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933. c. The Preferred Stock and Warrant Purchase Agreement between Universal Hospital Services, Inc. and ReliaStar Financial Corp. dated December 18, 1998, pursuant to which the Company has 6,246 shares of its Series B 13% Cumulative Accruing Pay-In-Kind Preferred Stock ("Series B Preferred Stock") issued and outstanding, and the letter dated September 26, 2003, pursuant to which the Company has agreed to declare a dividend of additional shares of Series B Preferred Stock as described in paragraph 2 of such letter. All of the Series B Preferred Stock is being repurchased concurrently with the closing of the Credit Agreement pursuant to a letter agreement dated September 26, 2003 between the Company and Security Life of Denver Insurance Company. d. The severance agreements with each of ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇, ▇▇▇▇▇▇ ▇. ▇▇▇▇▇, ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ and ▇▇▇▇ ▇. ▇▇▇▇▇▇▇ provide for the continued exercisability of their respective options to purchase common stock of the Company. Pursuant to an Information Memorandum of the Company dated September 29, 2003, the Company is offering to repurchase outstanding options and warrants to purchase its common stock. e. Under the Stock Purchase Agreement dated as of September 26, 2003, as amended by Amendment No. 1 to Stock Purchase Agreement to be executed concurrently with the closing of the Credit Agreement, by and between the Company, ▇.▇. Childs Equity Partners III, L.P., JWC Fund III Co-invest LLC, Halifax Capital Partners, L.P., and the Management Holders who have executed and delivered a Joinder Agreement to the Stock Purchase Agreement, the Company will issue 4,645,833.33 shares of common stock, and may issue after the closing of the Credit Agreement, an additional 33,000 shares of common stock. f. As contemplated or required by the Stock Purchase Agreement, as amended by the Amendment No. 1 to Stock Purchase Agreement, the Company intends to enter into a new stock option plan and intends to enter into a new Employment Agreement with ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ concurrently with the closing of the Credit Agreement. The Company has obtained written agreements from ▇▇. ▇▇▇▇▇▇▇▇▇ and holders of "super achiever" options to sell their shares and options in connection with the Recapitalization. In connection with the Recapitalization, the Company will grant an additional 20,000 stock options to ▇▇. ▇▇▇▇▇▇▇▇▇. Concurrently with the closing of the Credit Agreement, the Company will grant ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ 6,000 stock options and execute an amended and restated Stockholders' Agreement with ▇.▇. Childs Equity Partners III, L.P., ▇.▇. Childs Equity Partners, L.P., Halifax Capital Partners, L.P., ▇▇▇▇ ▇▇▇▇▇▇▇▇▇, and ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇. ## Denotes confidential information that has been omitted from the exhibit and filed separately, accompanied by a confidential treatment request, with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933. SCHEDULE 1 TO DISCLOSURE SCHEDULE 3.8 NAME TOTAL # OF SHARES ------------------------------------------------------------- ▇.▇. Childs Equity Partners, L.P. ## ------------------------------------------------------------- JWC-UHS Co-Invest LLC ## ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ▇▇▇▇▇▇ ▇. ▇▇▇▇▇* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ▇▇▇▇▇▇ ▇. ▇▇▇* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## Denotes confidential information that has been omitted from the exhibit and filed separately, accompanied by a confidential treatment request, with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933. ------------------------------------------------------------- ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ ## ------------------------------------------------------------- ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ & ▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ ## ------------------------------------------------------------- ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ ## ------------------------------------------------------------- ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ ## ------------------------------------------------------------- ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ## ------------------------------------------------------------- ▇▇▇▇ ▇. ▇▇▇▇▇ ## ------------------------------------------------------------- ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ ## ------------------------------------------------------------- ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ▇▇▇▇ ▇. ▇▇▇▇▇▇ ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## Denotes confidential information that has been omitted from the exhibit and filed separately, accompanied by a confidential treatment request, with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933. ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## Denotes confidential information that has been omitted from the exhibit and filed separately, accompanied by a confidential treatment request, with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933. ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- JWC Fund III Co-invest LLC ## ------------------------------------------------------------- Halifax Capital Partners, L.P. ## ------------------------------------------------------------- ▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ ## ------------------------------------------------------------- ----------- * JWC-UHS Co-Invest LLC holds the stockholder's stock for the benefit of the stockholder ## Denotes confidential information that has been omitted from the exhibit and filed separately, accompanied by a confidential treatment request, with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933. SCHEDULE 2 TO SCHEDULE 3.8 TO CREDIT AGREEMENT OUTSTANDING SHARES OF COMMON STOCK (see attached) ## Denotes confidential information that has been omitted from the exhibit and filed separately, accompanied by a confidential treatment request, with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933. SCHEDULE 2 TO DISCLOSURE SCHEDULE 3.8 AND SCHEDULE 1 TO DISCLOSURE SCHEDULE 3.22 1998 STOCK OPTION PLAN EMPLOYEE NAME GRANT DATE EXPIRATION ISSUED EXERCISED FORFEITED EXPIRED OUTSTANDING VESTED NONVESTED ------------- ---------- ---------- ------------ --------- --------- ------- ------------ ------------ ------------ ▇▇▇▇▇ ▇. ▇▇▇▇▇ 06/09/1992 06/09/2002 7,000.00 7,000.00 0.00 0.00 0.00 0.00 0.00 ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 06/09/1992 06/09/2002 7,000.00 7,000.00 0.00 0.00 0.00 0.00 0.00 ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 06/09/1992 06/09/2002 5,250.00 5,250.00 0.00 0.00 0.00 0.00 0.00 ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 06/09/1992 06/09/2002 2,100.00 2,100.00 0.00 0.00 0.00 0.00 0.00 ▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 06/09/1992 06/09/2002 2,100.00 2,100.00 0.00 0.00 0.00 0.00 0.00 ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 06/09/1992 06/09/2002 7,000.00 7,000.00 0.00 0.00 0.00 0.00 0.00 ▇▇▇▇▇▇ ▇. ▇▇▇▇▇ 06/09/1992 06/09/2002 7,000.00 7,000.00 0.00 0.00 0.00 0.00 0.00 ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ 06/09/1992 06/09/2002 35,000.00 35,000.00 0.00 0.00 0.00 0.00 0.00 ▇▇▇▇▇▇▇ ▇ ▇▇▇▇▇▇▇▇▇ 06/09/1992 06/09/2002 2,100.00 0.00 2,100.00 0.00 0.00 0.00 0.00 ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 01/20/1993 01/20/2008 14,000.00 0.00 0.00 0.00 14,000.00 14,000.00 0.00 ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ 01/20/1993 01/20/2008 70,000.00 0.00 0.00 0.00 70,000.00 70,000.00 0.00 ▇▇▇▇▇ ▇. ▇▇▇▇▇ 01/20/1994 01/20/2004 7,700.00 0.00 0.00 0.00 7,700.00 7,700.00 0.00 ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ 01/20/1994 01/20/2004 7,700.00 0.00 0.00 0.00 7,700.00 7,700.00 0.00 ▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 01/20/1994 01/20/2004 7,700.00 0.00 0.00 0.00 7,700.00 7,700.00 0.00 ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 01/20/1994 01/20/2004 24,500.00 0.00 0.00 0.00 24,500.00 24,500.00 0.00 ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 01/20/1994 01/20/2004 8,169.00 0.00 0.00 0.00 8,169.00 8,169.00 0.00 ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ 01/20/1994 01/20/2004 7,700.00 0.00 0.00 0.00 7,700.00 7,700.00 0.00 ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ 01/20/1994 01/20/2004 87,500.00 0.00 0.00 0.00 87,500.00 87,500.00 0.00 ▇▇▇▇▇ ▇. ▇▇▇▇▇ 01/20/1995 01/20/2005 13,769.00 0.00 0.00 0.00 13,769.00 13,769.00 0.00 ## ## ## ## ## ## ## ## ## ## ▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 01/20/1995 01/20/2005 13,769.00 0.00 0.00 0.00 13,769.00 13,769.00 0.00 ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 01/20/1995 01/20/2005 21,910.00 0.00 0.00 0.00 21,910.00 21,910.00 0.00 ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 01/20/1995 01/20/2005 14,609.00 0.00 0.00 0.00 14,609.00 14,609.00 0.00 ## ## ## ## ## ## ## ## ## ## ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ 01/20/1995 01/20/2005 78,400.00 0.00 0.00 0.00 78,400.00 78,400.00 0.00 ▇▇▇▇▇ ▇. ▇▇▇▇▇ 01/19/1996 01/19/2006 19,740.00 0.00 0.00 0.00 19,740.00 19,740.00 0.00 ## Denotes confidential information that has been omitted from the exhibit and filed separately, accompanied by a confidential treatment request, with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933. ## ## ## ## ## ## ## ## ## ## ▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 01/19/1996 01/19/2006 19,740.00 0.00 0.00 0.00 19,740.00 19,740.00 0.00 ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 01/19/1996 01/19/2006 21,000.00 0.00 0.00 0.00 21,000.00 21,000.00 0.00 ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 01/19/1996 01/19/2006 21,000.00 0.00 0.00 0.00 21,000.00 21,000.00 0.00 ## ## ## ## ## ## ## ## ## ## ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ 01/19/1996 01/19/2006 75,180.00 0.00 0.00 0.00 75,180.00 75,180.00 0.00 ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 09/20/1996 09/20/2006 35,000.00 0.00 0.00 0.00 35,000.00 35,000.00 0.00 -------------------------------------------------------------------------------------- 710,654.00 72,450.00 2,100.00 0.00 636,104.00 636,104.00 0.00 ▇▇▇▇▇ ▇. ▇▇▇▇▇ 03/17/1998 03/17/2008 55,635.30 0.00 0.00 0.00 55,635.30 0.00 55,635.30 ▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 03/17/1998 03/17/2008 55,635.30 0.00 22,254.00 0.00 33,381.30 0.00 33,381.30 ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 03/17/1998 03/17/2008 55,
Appears in 3 contracts
Sources: Credit Agreement (Universal Hospital Services Inc), Credit Agreement (Universal Hospital Services Inc), Credit Agreement (Universal Hospital Services Inc)
Options, Warrants, etc. a. The Company has outstanding options to purchase a total of 3,151,756 shares of its common stock under its 1998 Stock Option Plan as of the date of the Stock Purchase Agreement. The name of each optionholder and the number of shares represented by each option grant is set forth on attached Schedule 2 to Disclosure Schedule 3.8, dated as of the date of the Stock Purchase Agreement. Pursuant to an Information Memorandum of the Company dated September 29, 2003, the Company is offering to repurchase for cash an aggregate of approximately $91 million, but not less than $70 million, worth of its outstanding common stock, $0.01 par value per share and outstanding options and warrants to purchase such stock.
b. On December 18, 1998, the Company issued to ReliaStar Financial Corp. ("Reliastar") a warrant (the "Warrant") to purchase 245,000 shares of the Company's common stock at an exercise price of $.01 per share. The Warrant was issued in connection with the Preferred Stock and Warrant Purchase Agreement, dated as of December 18, 1998, between the Company and Reliastar. The Warrant was subsequently transferred by Reliastar to Security Life of Denver Insurance Company, an affiliate of Reliastar. Pursuant to an Information Memorandum of the Company dated September 29, 2003, the Company is offering to repurchase outstanding options and warrants to purchase its common stock. Under the letter agreement dated September 26, 2003 between the Company and Security Life of Denver Insurance Company, Security Life of Denver Insurance Company agreed that the Company will repurchase the Warrant concurrently with the closing of the Credit Agreement. ## Denotes confidential information that has been omitted from the exhibit and filed separately, accompanied by a confidential treatment request, with the Securities and Exchange Commission pursuant to Rule 406 24b-2 of the Securities Exchange Act of 19331934.
c. The Preferred Stock and Warrant Purchase Agreement between Universal Hospital Services, Inc. and ReliaStar Financial Corp. dated December 18, 1998, pursuant to which the Company has 6,246 shares of its Series B 13% Cumulative Accruing Pay-In-Kind Preferred Stock ("Series B Preferred Stock") issued and outstanding, and the letter dated September 26, 2003, pursuant to which the Company has agreed to declare a dividend of additional shares of Series B Preferred Stock as described in paragraph 2 of such letter. All of the Series B Preferred Stock is being repurchased concurrently with the closing of the Credit Agreement pursuant to a letter agreement dated September 26, 2003 between the Company and Security Life of Denver Insurance Company.
d. The severance agreements with each of Michael R. Johnson, Robert H. Braun, Gerald L. Brandt and Gary L. ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ fo▇ ▇▇▇ ▇▇▇▇▇▇▇, ▇▇ e▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇. ▇ thei▇ ▇▇▇▇▇, ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ and ▇▇▇▇ ▇. ▇▇▇▇▇▇▇ provide for the continued exercisability of their respective options tions to purchase common stock of the Company. Pursuant to an Information Memorandum of the Company dated September 29, 2003, the Company is offering to repurchase outstanding options and warrants to purchase its common stock.
e. Under the Stock Purchase Agreement dated as of September 26, 2003, as amended by Amendment No. 1 to Stock Purchase Agreement to be executed concurrently with the closing of the Credit Agreement, by and between the Company, ▇.▇. J.W. Childs Equity Partners III, L.P., JWC Fund III Co-invest LLC, Halifax ▇alifax Capital Partners, L.P., and the Management Holders who have executed and delivered a Joinder Agreement to the Stock Purchase Agreement, the Company will issue 4,645,833.33 shares of common stock, and may issue after the closing of the Credit Agreement, an additional 33,000 shares of common stock.
f. As contemplated or required by the Stock Purchase Agreement, as amended by the Amendment No. 1 to Stock Purchase Agreement, the Company intends to enter into a new stock option plan and intends to enter into a new Employment Agreement with David Dovenberg concurrently with the closing of the Credit Agre▇▇▇▇▇. ▇▇▇ ▇▇▇▇▇▇▇▇▇ concurrently with the closing of the Credit Agreement. The Company any has obtained written agreements from ▇▇. ▇▇▇▇▇▇▇▇▇ Mr. Dovenberg and holders of "super achiever" options to sell their shares and th▇▇▇ ▇▇▇▇▇▇ ▇▇▇ options in connection with the Recapitalization. In connection with the Recapitalization, the Company will grant an additional 20,000 stock options to ▇▇. ▇▇▇▇▇▇▇▇▇Mr. Dovenberg. Concurrently with the closing of the Credit Agreement, the Company ▇▇▇ ▇▇▇pany will grant Samuel Humphries 6,000 stock options and execute an amended and ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ 6,000 stock options and execute an amended and restated Stockholderslders' Agreement with ▇.▇. J.W. Childs Equity Partners III, L.P., ▇.▇. J.W. Childs Equity PartnersPartne▇▇, L.P., Halifax Capital Partners, L.P., ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ary Blackford, and David Dovenberg. ## Denotes confidential infor▇▇▇▇▇▇ ▇▇▇▇ ▇▇s been ▇▇▇▇▇▇▇ ▇▇▇▇ ▇he exhibit and filed separately, accompanied by a confidential treatment request, with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934. SCHEDULE 1 TO DISCLOSURE SCHEDULE 3.8 ------------------------------------------------------------------------------------------------ Name Total # of Shares ------------------------------------------------------------------------------------------------ J.W. Childs Equity Partners, L.P. ## ------------------------------------------------------------------------------------------------ JWC-UHS Co-Invest LLC ## ------------------------------------------------------------------------------------------------ ##* ------------------------------------------------------------------------------------------------ ##* ------------------------------------------------------------------------------------------------ ##* ------------------------------------------------------------------------------------------------ ##* ------------------------------------------------------------------------------------------------ Steven G. Segal* ------------------------------------------------------------------------------------------------ ##* ------------------------------------------------------------------------------------------------ ##* ------------------------------------------------------------------------------------------------ ##* ------------------------------------------------------------------------------------------------ ##* ------------------------------------------------------------------------------------------------ ##* ------------------------------------------------------------------------------------------------ ##* ------------------------------------------------------------------------------------------------ ##* ------------------------------------------------------------------------------------------------ ##* ------------------------------------------------------------------------------------------------ ##* ------------------------------------------------------------------------------------------------ Edward D. Yun* ------------------------------------------------------------------------------------------------ ##* ------------------------------------------------------------------------------------------------ ##* ------------------------------------------------------------------------------------------------ ##* ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ ## Denotes confidential information that has been omitted from the exhibit and filed separately, accompanied by a confidential treatment request, with the Securities and Exchange Commission pursuant to Rule 406 24b-2 of the Securities Exchange Act of 19331934. SCHEDULE 1 TO DISCLOSURE SCHEDULE 3.8 NAME TOTAL # OF SHARES ------------------------------------------------------------- ▇.▇. Childs Equity Partners, L.P. ------------------------------------------------------------------------------------------------ David E. Dovenberg ## ------------------------------------------------------------- JWC-UHS Co-Invest LLC ------------------------------------------------------------------------------------------------ David E. Dovenberg & Jean M. Dovenberg ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ Robert E. Dovenberg ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ▇▇▇▇▇▇ ▇. ▇▇▇▇▇* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ▇▇▇▇▇▇ ▇. ▇▇▇* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- ##* ------------------------------------------------------------- # ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ Jean M. Dovenberg ## ------------------------------------------------------------------------------------------------ Samuel B. Humphries ## ------------------------------------------------------------------------------------------------ Gary Blackford ## ------------------------------------------------------------------------------------------------ John A. Gappa ## ------------------------------------------------------------------------------------------------ Jeffrey L. Singer ## ------------------------------------------------------------------------------------------------ Andrew R. Amicon ## ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ Judy M. Slater ## ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ Susan E. Ellington ## ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ ## Denotes confidential information that has been omitted from the exhibit and filed separately, accompanied by a confidential treatment request, with the Securities and Exchange Commission pursuant to Rule 406 24b-2 of the Securities Exchange Act of 19331934. ------------------------------------------------------------- ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ ## ------------------------------------------------------------- ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ & ▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ ## ------------------------------------------------------------- ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ ## ------------------------------------------------------------- ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ ## ------------------------------------------------------------- ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ## ------------------------------------------------------------- ▇▇▇▇ ▇. ▇▇▇▇▇ ## ------------------------------------------------------------- ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ ## ------------------------------------------------------------- ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ▇▇▇▇ ▇. ▇▇▇▇▇▇ ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------------------------------------------ ## Denotes confidential information that has been omitted from the exhibit and filed separately, accompanied by a confidential treatment request, with the Securities and Exchange Commission pursuant to Rule 406 24b-2 of the Securities Exchange Act of 19331934. ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ JWC Fund III Co-invest LLC ## ------------------------------------------------------------------------------------------------ Halifax Capital Partners, L.P. ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ Gary D. Blackford ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ## Denotes confidential information that has been omitted from the exhibit and filed separately, accompanied by a confidential treatment request, with the Securities and Exchange Commission pursuant to Rule 406 24b-2 of the Securities Exchange Act of 19331934. ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- ## ## ------------------------------------------------------------- JWC Fund III Co-invest LLC ## ------------------------------------------------------------- Halifax Capital Partners, L.P. ## ------------------------------------------------------------- ▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ ## ------------------------------------------------------------- ----------- ---------- * JWC-UHS Co-Invest LLC holds the stockholder's stock for the benefit of the stockholder ## Denotes confidential information that has been omitted from the exhibit and filed separately, accompanied by a confidential treatment request, with the Securities and Exchange Commission pursuant to Rule 406 24b-2 of the Securities Exchange Act of 19331934. SCHEDULE 2 TO SCHEDULE 3.8 TO CREDIT AGREEMENT OUTSTANDING SHARES OF COMMON STOCK (see attached) ## Denotes confidential information that has been omitted from the exhibit and filed separately, accompanied by a confidential treatment request, with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933. SCHEDULE 2 TO DISCLOSURE SCHEDULE 3.8 AND SCHEDULE 1 TO DISCLOSURE SCHEDULE 3.22 1998 STOCK OPTION PLAN EMPLOYEE NAME GRANT DATE EXPIRATION ISSUED EXERCISED FORFEITED EXPIRED OUTSTANDING VESTED NONVESTED ------------- ---------- ---------- ------------ --------- --------- ------- ------------ ------------ ------------ ▇▇▇▇▇ ▇. ▇▇▇▇▇ 06/09/1992 06/09/2002 7,000.00 7,000.00 0.00 0.00 0.00 0.00 0.00 ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 06/09/1992 06/09/2002 7,000.00 7,000.00 0.00 0.00 0.00 0.00 0.00 ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 06/09/1992 06/09/2002 5,250.00 5,250.00 0.00 0.00 0.00 0.00 0.00 ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 06/09/1992 06/09/2002 2,100.00 2,100.00 0.00 0.00 0.00 0.00 0.00 ▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 06/09/1992 06/09/2002 2,100.00 2,100.00 0.00 0.00 0.00 0.00 0.00 ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 06/09/1992 06/09/2002 7,000.00 7,000.00 0.00 0.00 0.00 0.00 0.00 ▇▇▇▇▇▇ ▇. ▇▇▇▇▇ 06/09/1992 06/09/2002 7,000.00 7,000.00 0.00 0.00 0.00 0.00 0.00 ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ 06/09/1992 06/09/2002 35,000.00 35,000.00 0.00 0.00 0.00 0.00 0.00 ▇▇▇▇▇▇▇ ▇ ▇▇▇▇▇▇▇▇▇ 06/09/1992 06/09/2002 2,100.00 0.00 2,100.00 0.00 0.00 0.00 0.00 ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 01/20/1993 01/20/2008 14,000.00 0.00 0.00 0.00 14,000.00 14,000.00 0.00 ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ 01/20/1993 01/20/2008 70,000.00 0.00 0.00 0.00 70,000.00 70,000.00 0.00 ▇▇▇▇▇ ▇. ▇▇▇▇▇ 01/20/1994 01/20/2004 7,700.00 0.00 0.00 0.00 7,700.00 7,700.00 0.00 ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ 01/20/1994 01/20/2004 7,700.00 0.00 0.00 0.00 7,700.00 7,700.00 0.00 ▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 01/20/1994 01/20/2004 7,700.00 0.00 0.00 0.00 7,700.00 7,700.00 0.00 ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 01/20/1994 01/20/2004 24,500.00 0.00 0.00 0.00 24,500.00 24,500.00 0.00 ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 01/20/1994 01/20/2004 8,169.00 0.00 0.00 0.00 8,169.00 8,169.00 0.00 ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ 01/20/1994 01/20/2004 7,700.00 0.00 0.00 0.00 7,700.00 7,700.00 0.00 ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ 01/20/1994 01/20/2004 87,500.00 0.00 0.00 0.00 87,500.00 87,500.00 0.00 ▇▇▇▇▇ ▇. ▇▇▇▇▇ 01/20/1995 01/20/2005 13,769.00 0.00 0.00 0.00 13,769.00 13,769.00 0.00 ## ## ## ## ## ## ## ## ## ## ▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 01/20/1995 01/20/2005 13,769.00 0.00 0.00 0.00 13,769.00 13,769.00 0.00 ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 01/20/1995 01/20/2005 21,910.00 0.00 0.00 0.00 21,910.00 21,910.00 0.00 ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 01/20/1995 01/20/2005 14,609.00 0.00 0.00 0.00 14,609.00 14,609.00 0.00 ## ## ## ## ## ## ## ## ## ## ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ 01/20/1995 01/20/2005 78,400.00 0.00 0.00 0.00 78,400.00 78,400.00 0.00 ▇▇▇▇▇ ▇. ▇▇▇▇▇ 01/19/1996 01/19/2006 19,740.00 0.00 0.00 0.00 19,740.00 19,740.00 0.00 ## Denotes confidential information that has been omitted from the exhibit and filed separately, accompanied by a confidential treatment request, with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933. ## ## ## ## ## ## ## ## ## ## ▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 01/19/1996 01/19/2006 19,740.00 0.00 0.00 0.00 19,740.00 19,740.00 0.00 ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 01/19/1996 01/19/2006 21,000.00 0.00 0.00 0.00 21,000.00 21,000.00 0.00 ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 01/19/1996 01/19/2006 21,000.00 0.00 0.00 0.00 21,000.00 21,000.00 0.00 ## ## ## ## ## ## ## ## ## ## ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ 01/19/1996 01/19/2006 75,180.00 0.00 0.00 0.00 75,180.00 75,180.00 0.00 ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 09/20/1996 09/20/2006 35,000.00 0.00 0.00 0.00 35,000.00 35,000.00 0.00 -------------------------------------------------------------------------------------- 710,654.00 72,450.00 2,100.00 0.00 636,104.00 636,104.00 0.00 ▇▇▇▇▇ ▇. ▇▇▇▇▇ 03/17/1998 03/17/2008 55,635.30 0.00 0.00 0.00 55,635.30 0.00 55,635.30 ▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 03/17/1998 03/17/2008 55,635.30 0.00 22,254.00 0.00 33,381.30 0.00 33,381.30 ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 03/17/1998 03/17/2008 55,Exchange
Appears in 1 contract